Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Solventum, the healthcare company spun off from 3M this year, has retained bankers to explore a sale of its purification and filtration business, according to people familiar with the matter. Shares ...
--Longest losing streak since Sept. 28, 2023, when it fell for 10 straight trading days --Worst six day stretch since the six days ending Jan. 30, 2024, when it fell 11.36% ...
M beats Q3 earnings expectations with margin expansion, but faces financial risks from PFAS liabilities and stock buybacks.
Solventum, the healthcare company spun off from 3M earlier this year, has retained bankers to explore a sale of its ...
Hartford Investment Management Co. lessened its position in shares of 3M (NYSE:MMM – Free Report) by 2.4% in the third ...
M (NYSE:MMM – Free Report) had its price target increased by Bank of America from $143.00 to $160.00 in a report issued on Wednesday, Benzinga reports. The firm currently has a buy rating on the ...